China Medical Epidemic Prevention Products Supplier List Market Outlook 2030: Industry Insights & Opportunity Evaluation, 2019-2030

$3,250$7,500

Disposable medical supplies are worn during surgical operations, medical testing, and chemotherapy to avoid cross-contamination between doctors and nurses, and doctors and patients.

Clear

Description

China Medical Epidemic Prevention Products Supplier List Market By Type (Diagnostic Supplies, Infusion & Injectable Supplies, Intubation & Ventilation Supplies, Disinfectants, Personal Protective Equipment, Sterilization Consumables, Wound Care Consumables, Dialysis Consumables, Radiology Consumables, Catheters, Sleep Apnea Consumables and Other Medical Supplies); By Application (Urology, Wound Care, Radiology, Respiratory, Infection Control, Cardiology, IVD and Other Applications); By End User (hospitals, physician clinics and others) and Region –Analysis of Market Size, Share and Trends for 2014 – 2019 and Forecasts to 2030.
Product Overview

Medical supplies are protective devices used against pathogens and diseases to protect healthcare personnel. Disposable medical supplies are worn during surgical operations, medical testing, and chemotherapy to avoid cross-contamination between doctors and nurses, and doctors and patients. Disposable medical supplies are an important part of the infection control strategy and FDA controls their use as medical equipment reserved for Class I use.
Market Highlights

China Medical Epidemic Prevention Products Supplier List Market size was registered at USD XX billion in 2019, and is estimated to reach USD XX billion by 2030, registering a CAGR of XX% from 2020 to 2030. During surgery and general patient care, low-cost medical supplies replace high-value added single-use items which will drive the growth of the Medical Supplies industry. Increasing demand for medical supplies, particularly gloves and face masks, is the major fueling factor for the Medical Supplies market due to increased awareness among workers regarding hygiene and safety. The key demand drivers in this sector are increasing geriatric population, increasing number of patients with chronic diseases such as cardiovascular, renal, diabetes, hypertension and others.
China Medical Epidemic Prevention Products Supplier List Market: Segments

China Medical Epidemic Prevention Products Supplier List Market is segmented on the basis of type, application, end user and region.

By Type (in %), China Medical Epidemic Prevention Products Supplier List Market, 2019
The Intubation & Ventilation Supplies segment is anticipated to register XX% of the market share during the forecasted period.
By type the market can be segmented into Diagnostic Supplies, Infusion & Injectable Supplies, Intubation & Ventilation Supplies, Disinfectants, Personal Protective Equipment, Sterilization Consumables, Wound Care Consumables, Dialysis Consumables, Radiology Consumables, Catheters, Sleep Apnea Consumables and Other Medical Supplies. During the forecast period the segment of intubation and ventilation consumables is expected to rise at the highest CAGR. This is due to the increased occurrence of respiratory disorders, such as asthma and COPD, as well as the growing prevalence of COVID-19 in the region.
China Medical Epidemic Prevention Products Supplier List Market Dynamics:

Increasing geriatric population and low-cost material cost to increase market growth
The key demand drivers in this sector are increasing geriatric population, increasing number of patients with chronic diseases such as cardiovascular, renal, diabetes, hypertension and others. Development would contribute to safety-enhanced tools for the minimally invasive delivery of parenteral medications, inhalation therapies, and IV and dialysis solutions.
Low financial resources to hinder the market growth in China
Healthcare providers have low financial resources, especially in developing countries such as China, to invest in such expensive sophisticated technologies.
China Medical Epidemic Prevention Products Supplier List Market: Regions

In terms of value and volume, China accounted for XX% of total market volume share in 2019
Healthcare reform has been one of the primary issues on the Chinese policy agenda. Due to the rise in healthcare costs, more than 10 percent of the income is spent on healthcare, which is higher than that spent on education and transportation. The rise in healthcare costs will likely result from the rising medication prices. Rapid consolidation between medium and large players in the sector is expected as the Chinese government has promoted industry consolidation in an attempt to regulate the industry and better control drug pricing. There are about 4500 pharmaceutical companies in China, most of which are small players in restricted local market presence.
China Medical Epidemic Prevention Products Supplier List Market: Competitive landscape

Some factors that improve the role in the market of the key players within the China Medical Epidemic Prevention Products Supplier List Market have been the improvement in healthcare facilities among key players and availability of favorable reimbursement policies and FDA approvals in developed regions coupled with the growth in preference for minimally invasive procedures.
China Medical Epidemic Prevention Products Supplier List Market: Key players

• Sinopharm Group
o Company Overview
o Business Strategy
o Key Product Offerings
o Financial Performance
o Key Performance Indicators
o Risk Analysis
o Recent Development
o Regional Presence
o SWOT Analysis
• Shanghai Pharmaceuticals
• Jiangsu Hengrui Medicine
• CEO: Sun Piaoyang
• Guangzhou Baiyunshan Pharmaceutical
• China Meheco
• Huadong Medicine
• Yunnan Baiyao
• Shanghai Fosun Pharmaceutical
• Other prominent players
China Medical Epidemic Prevention Products Supplier List Market report also contains analysis on:

• China Medical Epidemic Prevention Products Supplier List Market segments: –

• By Type:

o Diagnostic Supplies
o Infusion & Injectable Supplies
o Intubation & Ventilation Supplies
o Disinfectants
o Personal Protective Equipment
o Sterilization Consumables
o Wound Care Consumables
o Dialysis Consumables
o Radiology Consumables
o Catheters
o Sleep Apnea Consumables
o Other Medical Supplies

• By Application:

o Urology
o Wound Care
o Radiology
o Respiratory
o Infection Control
o Cardiology
o IVD
o Other Applications

• By End User:
o hospitals
o physician clinics
o other

• China Medical Epidemic Prevention Products Supplier List Market dynamics
• China Medical Epidemic Prevention Products Supplier List Market size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies Involved in the Market
• Value Chain of the Market
• Market Drivers and Restraints

Additional information

Publisher

Geography Covered

Date Published

,

Pages

Format

Table of Contents

1. Executive Summary
2. China Medical Epidemic Prevention Products Supplier List Market
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. Research Methodology
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. Average Pricing Analysis
5. Market Dynamics
5.1. Growth Drivers
5.2. Restraints
5.3. Opportunity
5.4. Trends
6. Correlation & Regression Analysis
6.1. Correlation Matrix
6.2. Regression Matrix
7. Recent Development, Policies & Regulatory Landscape
8. Risk Analysis
8.1. Demand Risk Analysis
8.2. Supply Risk Analysis
9. China Medical Epidemic Prevention Products Supplier List Market Analysis
9.1. Porters Five Forces
9.1.1. Threat of New Entrants
9.1.2. Bargaining Power of Suppliers
9.1.3. Threat of Substitutes
9.1.4. Rivalry
9.2. PEST Analysis
9.2.1. Political
9.2.2. Economic
9.2.3. Social
9.2.4. Technological
10. China Medical Epidemic Prevention Products Supplier List Market
10.1. Market Size & forecast, 2019A-2030F
10.1.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
10.1.2. By Volume (Million Units) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11. China Medical Epidemic Prevention Products Supplier List Market: Market Segmentation

11.1.1. East China:
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11.1.2. South China:
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11.1.3. North China:
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
11.1.4. West China:
• By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F

12. China Medical Epidemic Prevention Products Supplier List Market: Market Segmentation
12.1. By type: Market Share (2020-2030F)
12.1.1. Diagnostic Supplies, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.2. Infusion & Injectable Supplies, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.3. Intubation & Ventilation Supplies, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.4. Disinfectants, Personal Protective Equipment, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.5. Sterilization Consumables, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.6. Wound Care Consumables, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.7. Dialysis Consumables, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.8. Radiology Consumables, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.9. Catheters, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.10. Sleep Apnea Consumables, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.1.11. Other Medical Supplies, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2. By application : Market Share (2020-2030F)
12.2.1. Urology, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.2. Wound Care, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.3. Radiology, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.4. Respiratory, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.5. Infection Control, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.6. Cardiology, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.7. IVD, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.2.8. Others, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.3. By end user: Market Share (2020-2030F)
12.3.1. Hospitals, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.3.2. Physical Clinics, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
12.3.3. Others, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F

13. Company Profile
13.1. Sinopharm Group
13.1.1. Company Overview
13.1.2. Company Total Revenue (Financials)
13.1.3. Market Potential
13.1.4. Global Presence
13.1.5. Key Performance Indicators
13.1.6. SWOT Analysis
13.1.7. Product Launch
13.2. Shanghai Pharmaceuticals
13.3. Jiangsu Hengrui Medicine
13.4. CEO: Sun Piaoyang
13.5. Guangzhou Baiyunshan Pharmaceutical
13.6. China Meheco
13.7. Huadong Medicine
13.8. Yunnan Baiyao
13.9. Shanghai Fosun Pharmaceutical
13.10. Other prominent players

14. Consultant Recommendation
**The above given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.

RSS
Follow by Email